NAYA Wutah pendapatan triwulanan NAYA Biosciences

Logo perusahaan publik NAYA Biosciences Inc. (NAYA)

NAYA Biosciences is currently integrating assets following the merger, focusing on preclinical stages and the search for partners. Long-term patents form the business foundation, ensuring a future monopoly. The company's quarterly revenue growth demonstrates current dynamics, where 479.00 represents the current metric level. Development relies on the Flex-NK platform to create low-toxicity drugs targeting solid tumors.

NAYA Biosciences Inc (NAYA) - Tambahing pendapatan triwulanan saka 04.07.2022 nganti 28.04.2025

Rincian metrik lan analitis perusahaan NAYA Biosciences Inc (NAYA)

Analisis dhasar perusahaan:NAYA - nayabiosciences.com
Produk sing diprodhuksi NAYA Biosciences Inc.

For the young biotech NAYA (NAYA), which focuses on preclinical oncology platforms without external expansion, quarterly sales growth serves as an indicator of the monetization efficiency of current assets. This metric captures the percentage change in revenue per quarter, allowing investors to assess cash flow dynamics and compare revenue growth rates with the stock price to identify if the asset is overbought.

Pesaing NAYA Biosciences

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aura Corp|CADL: Wutah pendapatan triwulanan|ARAY - Tingkat wutah dodolan sajrone kuartal|SLS (SELLAS Life Sciences Group, Inc.) - Wutah pendapatan triwulanan|ACTU: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal citiusonc.com (CTOR)|Tingkat wutah dodolan sajrone kuartal TuHURA Biosciences|Wutah pendapatan kuartal marang kuartal Protara Therapeutics TARA|Fate Therapeutics (FATE) - Tingkat wutah pendapatan sajrone kuartal|WHWK - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal TScan Therapeutics Inc|championsoncology.com (CSBR) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal XBIT|Wutah dodolan triwulanan CVM|Wutah dodolan kuartal marang kuartal OSTX (OS Therapies Incorporated)|Wutah pendapatan triwulanan RADX|ARTV: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan ANL (Adlai Nortye Ltd)|VERU - Wutah dodolan triwulanan|tempesttx.com - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan XLO (xiliotx.com)|RENB: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Mural Oncology plc|Wutah pendapatan kuartal marang kuartal Kairos Pharma Inc|OKUR: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan GDTC|CRIS (Curis) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal apollomicsinc.com APLM|THAR: Wutah dodolan kuartal marang kuartal|advanbiomed.com - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Wutah pendapatan kuartal marang kuartal|Sunshine Biopharma Inc. (SBFM) - Wutah pendapatan triwulanan|XBIO (Xenetic Bio) - Wutah pendapatan triwulanan|Salarius Pharmaceuticals Inc (SLRX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PPBT|Wutah pendapatan triwulanan American Oncology Network Inc (AONC)|Wutah pendapatan triwulanan BGNE (BeiGene Ltd.)|Owah-owahan dodolan kuartal marang kuartal CKPT (Checkpoint Therapeutics)|ELEV - Wutah pendapatan kuartal marang kuartal|ICAD (iCAD Inc.) - Wutah dodolan kuartal marang kuartal|Ikena (IKNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Notable Labs, Ltd.|Wutah pendapatan kuartal marang kuartal viracta.com|MOR: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)